InvestorsHub Logo
Followers 7
Posts 225
Boards Moderated 0
Alias Born 10/20/2010

Re: None

Tuesday, 05/25/2021 9:29:59 AM

Tuesday, May 25, 2021 9:29:59 AM

Post# of 403752
Does it sound like Brilacidin has safety issues?

WAKEFIELD, MA – April 5, 2021 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announced that an independent Data Monitoring Committee (DMC) completed its scheduled review of interim safety data in the Company’s randomized, double-blind, placebo-controlled Phase 2 clinical trial of Brilacidin for treatment of moderate-to-severe COVID-19 in hospitalized patients.